EUVIMEDEUVIMED entdecken
ÄquivalenzstudieMultizentrische StudieRandomisierte kontrollierte Studie

Efficacy of Tetracycline Three Times Daily was Comparable to That of Four Times Daily for Helicobacter pylori Rescue Treatment: A Multicenter, Noninferiority, Randomized Controlled Trial

Zhongxue Han, Qiumei Zhang, Iqtida Ahmed Mirza, Yuming Ding, Xueping Nan, Qing Zhao, Ruili Li, Lidong Xu, Ning Zhang, Miao Duan, Shuyan Zeng, Qingzhou Kong und 6 weitere

Helicobacter · 2024

DOI: 10.1111/hel.13102 ↗

Kurz gefasst

Äquivalenzstudie in der Zeitschrift Helicobacter, 2024. Verfasst von Zhongxue Han und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Helicobacter Infections, Helicobacter pylori, Tetracycline. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The optimal dosage of tetracycline remains unclear for Helicobacter pylori eradication. Frequent dosing requirements may decrease patient adherence and increase the incidence of adverse events, potentially reducing treatment efficacy. This study aimed to compare the efficacy of different tetracycline dosages in rescue treatment for H. pylori infection.

Methods

A total of 406 patients needing H. pylori rescue treatment were enrolled. Patients were randomized into two groups and received bismuth‐containing quadruple therapies as follows: esomeprazole 40 mg twice daily, bismuth 220 mg twice daily, amoxicillin 1000 mg twice daily, and tetracycline 500 mg either three (TET‐T group) or four (TET‐F group) times daily. At least 6 weeks after treatment completion, a 13 C‐urea breath test was performed to evaluate H. pylori eradication.

Results

The intention‐to‐treat (ITT) eradication rates were 91.13% (185/203) and 90.15% (183/203) ( p = 0.733), the modified ITT (MITT) eradication rates were 94.87% (185/195) and 95.31% (183/192) ( p = 0.841), and the per‐protocol (PP) eradication rates were 94.79% (182/192) and 95.21% (179/188) ( p = 0.851) in the TET‐T group and TET‐F group, respectively. The eradication rates for the TET‐T group were not inferior to those of the TET‐F group in ITT, MITT, and PP analyses. The incidence of adverse effects was significantly lower in the TET‐T group than in the TET‐F group (23.65% vs. 33.50%, p = 0.028). No significant differences were observed in treatment compliance between the groups.

Conclusions

The dose of tetracycline administered three times daily showed comparable efficacy to that administered four times daily, while significantly reducing the incidence of adverse events. The combination of tetracycline and amoxicillin in bismuth‐containing quadruple therapy achieved a high eradication rate in H. pylori rescue treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsHelicobacter InfectionsHelicobacter pyloriTetracyclineAdultAgedFemaleHumansMaleMiddle AgedAmoxicillinBismuthBreath TestsDrug Administration ScheduleDrug Therapy, CombinationEsomeprazoleTreatment Outcome

Substanzen

AmoxicillinAnti-Bacterial AgentsBismuthEsomeprazoleTetracycline

Autor:innen und Institutionen

  • Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
  • Laboratory of Translational Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
  • Shandong Provincial Clinical Research Center for Digestive Disease, Qilu Hospital of Shandong University, Jinan, Shandong, China.
  • Department of Gastroenterology, Yuncheng Traditional Chinese Medicine Hospital, Heze, Shandong, China.
  • Department of Gastroenterology, Zibo Central Hospital, Zibo, Shandong, China.
  • Department of Gastroenterology, Taierzhuang District People's Hospital, Zaozhuang, Shandong, China.

ORCID-Profile: Xiuli Zuo, Yanqing Li, Yueyue Li

Zitieren

APA

Han, Z., Zhang, Q., Mirza, I. A., Ding, Y., Nan, X., Zhao, Q., Li, R., Xu, L., Zhang, N., Duan, M., Zeng, S., Kong, Q., Zhang, W., Wang, H., Wu, X., Zuo, X., Li, Y., & Li, Y. (2024). Efficacy of Tetracycline Three Times Daily was Comparable to That of Four Times Daily for Helicobacter pylori Rescue Treatment: A Multicenter, Noninferiority, Randomized Controlled Trial. Helicobacter. https://doi.org/10.1111/hel.13102

Vancouver

Han Z, Zhang Q, Mirza IA, Ding Y, Nan X, Zhao Q, et al. Efficacy of Tetracycline Three Times Daily was Comparable to That of Four Times Daily for Helicobacter pylori Rescue Treatment: A Multicenter, Noninferiority, Randomized Controlled Trial. Helicobacter. 2024. doi:10.1111/hel.13102

BibTeX
@article{Han2024,
  author = {Han, Zhongxue and Zhang, Qiumei and Mirza, Iqtida Ahmed and Ding, Yuming and Nan, Xueping and Zhao, Qing and Li, Ruili and Xu, Lidong and Zhang, Ning and Duan, Miao and Zeng, Shuyan and Kong, Qingzhou and Zhang, Wenlin and Wang, Hui and Wu, Xiaoqi and Zuo, Xiuli and Li, Yanqing and Li, Yueyue},
  title = {Efficacy of Tetracycline Three Times Daily was Comparable to That of Four Times Daily for Helicobacter pylori Rescue Treatment: A Multicenter, Noninferiority, Randomized Controlled Trial},
  journal = {Helicobacter},
  year = {2024},
  doi = {10.1111/hel.13102}
}
Kostenlos starten →